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The gene structure of the human lysosomal enzyme glycosylasparaginase was determined. The gene spans 13 kb and consists of 9 exons. Both 
5’ and 3’ untranslated regions of the gene are unintcrru,.* n**d by introns. A number of transcriptional elements were identified in the 5’ upstream 
sequence that includes two putative CAAT boxes followed by TATA-like sequences together with two AP-2 binding sites and one for SpI. A 
100 bp CpG island and several ETF binding sites were also found. Additional AP-2 and Spl binding sites are present in the first irltron. Two 
polyadenylation sites are present and appear to be functional. The major known glycosylasparaginase gene defect Wa8+C, which causes the lysoso- 
ma1 storage disease aspartylglycosaminuria (AGU) in Finland, is located in exon 4. Exon 5 encodes the post-translational c eavage site for the 
formation of the mature cl//I subunits of the enzyme as well as a recently proposed active site threonine, Th?06. 
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1. INTRODUCTION 
Glycosylasparaginase (EC 3.5.1.26) is a lysosomal 
amidase which cleaves the GlcNAc-Asn bond that 
forms the linkage between peptide and oligosaccharide 
in Asn-linked glycoproteins [ 11. The importance of this 
reaction in the degradation of glycoproteins is em- 
phasized by the occurrence of aspartylglucosaminuria 
(AGU), a lysosomal storage disease caused by glyco- 
sylasparaginase deficiency [2]. AGU patients ac- 
cumulate GlcNAc-Asn in lysosomes and typically 
become mentally retarded and show physical deteriora- 
tion as juveniles, but can survive beyond four decades. 
AGU is genetically inherited as an autosomal recessive 
trait and is found mainly in Finland [2]. The estimated 
incidence of AGU in Finland is approximately 1:26000 
and the heterozygote carrier frequency is as high as 1:40 
in northern Finland [3]. 
Rat liver g!ycosylasparaginase has previously been 
purified and well characterized in this laboratory and 
was found to be a 49 kDa heterodimer composed of 24 
and 20 kDa subunits joined by non-covalent bonding 
[4]. The human enzyme has been purified [5-7) and 
recently we [8], and later scientists at the Finnish Na- 
tional Public Health Institute [9], reported the cloning 
of a cDNA for human glycosylasparaginase. A single 
gene encodes the enzyme which has a deduced 
molecular weight of 34.6 kDa, The two subunits, 23 
kDa (Q) and 17-18 kDa (/3), are produced by post- 
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translational proteolytic cleavage [8, IO]. The gene has 
been previously mapped to cheomosome 4 and its size 
estimated to be 15 kb [9]. 
We have now isolated a genomic clone of human 
glycosylasparaginase and are reporting its structure in- 
cluding the 5’ untranslated sequence. This new infor- 
mation will allow a better characterization of the 
molecular nature of the disease AGU in all its forms as 
more patients are diagnosed. 
2. MATERIALS AND METI-IODS 
2. I. Malerials 
The sources of the major experimental materials used in this work 
were as follows: a XFixII human genomic library from Stratagene, 
restriction enzymes and random-primed labeling kit from Boehringcr 
Mannheim, biotinyl-I I-dUTP from Sigma, [a-3sS]dCTP from New 
England Nuclear-DuPont, Hybond N membranes from Amersham, 
Scquenasc version 2.0 DNA sequencing kit from Uniled Starts 
Biocbcmical Co. 
2.2. Merirods 
Human glycosylasparaginase cDNA insert HPAsn.G [S] was labeled 
with biotinyl-1 I-dUTP by random-primed labcling and used as a pro- 
bc to screen the genomic library [I I]. Phage DNA was prepared and 
analyzed by restriction enzyme digestion and Southern blotting [lt]. 
Fragments which had exons were subcloncd into pUC18, pBlucscript 
II SK( + 1, or M 13mp lW19, and further analyzed or sequenced by the 
didcoxynucleotidc chain termination method [i3]. dlTP was used to 
scqucncc GC rich regions. Restriction maps wcrc’ constructed by 
multiple or partial restriction cnzymc digestions. 
3. RESULTS AND DISCUSSION 
3.1 . isokur ion and cltarac!erizariotl of the 
glycosylasparaginase gene 
1 X IO6 phagcs of the XFixII human gcnomic library 
were screened and 6 positive clones were obtained after 
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Fig. 1, Organization and restriction map of the human glycosylasparaginase gene. The schematic structure of the gene is shown at the top. Exons 
are represented by open boxes and black areas indicate non-coding regions. Open bars at the bottom of the figure denote inserts of two genomic 
clones, MlGA.1 I and AHGA.121. Subclones used for sequence analysis are shown above these two primary genomic ClonCs. Partial SeqUCnCing 
of these subclones included only exons and exon-intron boundaries. 
four rounds of screening, By restriction mapping two of 
the positive clones, XHGA.11 and XHGA.121, were 
found to contain the longest segments of 5’ or 3’ SC% 
quence present in cDNA HPAsn.6, and they were 
. 
chosen for further analysis (Fig. 1). Phage DNA was 
digested with Not1 to release the genomic DNA inserts 
which were further fragmented with EcoRi. The 
fragments which hybridized with cDNA were eluted 
Table I 
Nucleotidc sequence of the intron-exon boundaries in the human glycosylasparaginase gene. Exon sequences are in upper-case letters; intron 
sequences are in lowercase. Consensus sequences at the 5’ and 3’ borders of introns are shown at the bottom. 
Exon size 
tbp) 
-- Sequence of intron-exon junction 
5’ Border 3’ Border lntron size 
(kb) ~____ 
> 640 
I54 
113 
113 
115 
76 
108 
134 
1040 
GAA 
ATG 
GAG 
TAT 
ACT 
ATA 
CTG 
AGT 
GCA G 
127 
ggalttgattaacz CG 
128 
GAT GG gtaga 
281 
TCA G gatt 
394 
TGG AGG @tug 
507 
ATT G @aat 
622 
CAT GG !pQ! 
698 
CCA AC gtatg 
8OG 
TAC G ylaag 
Y40 
tcrattttcrtgcs C 
282 
ttttccaatctcc;lg cc 
395 
aaatcttgtttags AAT 
SO8 
tttttlnacttctag GC - 
623 
aataccctctcaaag C - 
699 
ctclgrttcaatcag C 
807 
catttttggccccilp GT 
941 
TGG AGG 2.1 
ACT ACT 0.7 
ACC ACA 0.9 
GTT ATA I.2 
ATG GTT 0.9 
CGT GTA 1.9 
TAC CAA 1.1 
GCT GCT I.5 
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from the agarose gel and separately subcloncd into 
pUC18 or pBluescript II. HincII and PuuII were used 
for further dissection of subclones (Fig. I), and 
fragments with exons were subcloned into 
M13mp18/19 and sequenced. 
The glycosylasparaginase gene spans approximately 
13 kb and consists of 9 exons. Exon 1 encodes 5 ’ un- 
translated sequence and the first 42 amino acids which 
include the 23 amino acid signai peptide. Exon 9 codes 
for the last 33 amino acids and a long 3’ untranslated 
sequence (939nt) which is not interrupted by an intron 
and includes three polyadenylation signals, two adja- 
cent at 1152 and 1164 and one at 1950 [9J, Ah in- 
tron-exon junctions fit the GT/AG consensus rule 
(Table I) [14]. Nucleotide sequences of coding regions 
agreed with those of the cDNA [8,9], but a major dif- 
ference was fcund in the 5’ non-coding region. Starting 
at 63 bp upsteam of the AK translation initiation 
codon (-63), the sequence of genomic DNA in the 5 ’ 
direction was completely different from that of the 
cDNA reported by Ikonen et al. [9] (Fig. 2). We do not 
think this is caused by the presence of an intron which 
splits the first exon. First, the sequence at the required 
intron-exon boundary does not fit either the GT/AG 
rufe (TT instead of AG (Fig, 2)) or other consensus 
structure at the 3’ border (GC-rich sequence instead of 
(Py)“N(Py)AG) 1141. Second, the genomic sequence 
shows several promoter elements 5 ’ upstream of this 
divergence site (Fig. 2). These facts support the idea 
that the first exon contains coding region and 5’ 
upstream sequence which is not interrupted by an in- 
tron. No significant match to this inconsistent sequence 
at the 5’ end of the cDNA was found in GenBank, and 
the sequence may have resulted from a cloning artifact. 
A single discrepancy also occurred in the 3’ un- 
translated region at + 1224 where A changed to C in the 
genomic DNA. This varied nucleotide might be a 
poIymorphism. 
3.2. 5 ’ untranslated region 
The 5 ’ untranslated region was sequenced to - 513. 
Based on the 2.3 kb size of glycosylasparaginase 
ATCAATCCGGTCCTAAGCAAACA 
AACTTTTCAACTTCAACTTTAAATTAAAkAGACAGTMAAGAACCAAATCCATAGTACACA~~~CGGC 
AP-2 
TAAAGTTCCTGGGGCCCTGCAACCCAGAGTTGA~+i+ATTC~$TCAAG+?+ 
~~~ATTT~AACCACAGGAAAAAGCAG~~CTTGT~TGGCTATTTTAAAAATCTGAACAGCACTTAGGAAGAA 
AP-2 
GCACCTTAGCGCAGGGAACAGCTCAGTGCCCCGTGACACA~CGCGGG~C~AGGGA~GC~TCGT~ 
TGTATTGAAACAATTTAATGAAAATATTAA 
SPl 
TCGCGAGAGTTGAGGGACGCCTGAGCGAACCCCCGAGAGAGCGGGCGTGGGCGCCAGGC~GGCAC 
ATATTTGGTTTCAAAAGGCAGATTTATCTTCTCCCAACATTCTGTTATTTCTGATACTTTTGAAAAACTA 
TGGG TTAATTGTTCGGCGATCGCTGGCTGCCGGGACTTTTCTCGCGCTGGTCTCTTCGGTGGTCAGGG b 
ATAAAAAC 
ATGGCGCGGAAGTCGAACTTGCCTGTGCTTCTCGTGCCGTTTCTGCTCTGCCAGGCCCTAGCGCGCTGCT 
CCAGCCCTCTGCCCCTGGTCGTCAACACTTGGCCCTTGGCCCTTT~G~TGC~~CG~GCAGgtgcgggttggcg 
AP-2 Spl Spl SPl 
gcctssscaqgcggctgcccgagagcttgcgcgtggggatgactagcccqccccgctgcagtcacccggc 
SPl 
gcgccgctcagtctcttgcaagtcgcctttactgcatcctccccacctaccgctgttgcattttagcgtc 
ctcccttcatgcagccccccagcgcy .tgtattttccaccctgctgctgaccatagttatggcctttgtg 
-491 
-421 
-351 
-281 
-211 
-141 
-71 
-1 
70 
140 
210 
280 
350 
420 
Fig. 2. Nuclcotidc scqucncc of the 5’ regioli of the human glycosylasparaginasc gcnc. Nucleotidc A of rhc initiation codon ATG is dcsinatcd + I. 
The first intron is in lower-wc Icttcrs. Putative CAAT and TATA motifs arc boxed. AP-2 sites arc ovcrscorcd and Sp I sites arc double-undcrlincd. 
The scqucncc b twert the brackets is a CpG island, The urtdcrmtlth sequence irt capital lcttcrs depicts the scqucwc a~ zhc 5’ crrd of D full-length 
c5NA rcportcd by lkonctl ct al. (91 that differs from the corresponding genomic scqucnce. 
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message which was detected in human fibroblasts [lo], 
we can estimate the approximate location of the pro- 
moter site to be near -250. There are 2 CAAT boxes 
both of which fall in this region (- 358 and -298) and 
are followed by TATA-like sequences (-316, -308, 
-286, and -280). So far, among lysosomal enzymes it 
is known that @-hexosaminidase (Y subunit [15], w 
galactosidase A [ 161, and cathepsin G [ 171 genes have 
both TATA and CAAT boxes in their 5 ’ flanking 
region. P-hexosaminidase 0 subunit [lg], cathepsin L 
1191, a-glucosidase [20], acid phosphatase [21], and 
arylsulfatase A [22] genes either lack these promoter 
elements or have only a CAAT box and show features 
of housekeeping enes that lack a TATA box, e.g. the 
presence of a GC-rich region, GC box, and other 
upstream promoter elements [23,24]. The 5 ’ flanking 
regior! of the glycosylasparaginase gene also has some 
characteristics of housekeeping genes. It has two poten,. 
tial AP-2 sites [24] at - 343 and - 157 and one potential 
Spl site [24] at -81. Interestingly, more AP-2 and Spl 
sites were found in the first intron: AP-2 site at 142, Spl 
sites at 145, 149, 187, and 252. The rat cathepsin L gene 
also has been found to have promoter elements in its 
first intron [19], but it is not known whether they are 
functional. A 100 bp GC-rich region (78%) was located 
between - 165 and -66, and the CpG/GpC ratio was 
14/13. The length of this CpG island [25], however, is 
relatively short compared to others which are several 
hundred bp [26]. Binding motifs (CCCC or GGGG) of 
ETF, a transcriptional factor which stimulates 
transcription from TATA box-lacking promoters [27], 
were found in the 5’ upstream region at -340, - 182, 
- 111, -96, and - 77. The 5’ upstream region of 
glycosylasparaginase g ne has features of both TATA 
box-containing and TATA box-lacking promoters. Fur- 
ther investigations are therefore necessary to determine 
precisely where transcription starts and which upstream 
elements actually function in the expression of the 
glycosylasparaginase g ne. 
3.3. 3 ’ untranslated region 
Exon 9 contains the last 34 codons followed by a 939 
bp 3’ untranslated region (Fig. 1, see also [8,9]. Three 
distinct polyadenylation signals were found in this ex- 
on, two adjacent at 1152 and 1164 [8,9] and a third at 
1950 [9]. These two polyadenylation sites are separated 
by approximately 800 bp and interruption by an intron 
is unlikely, since a single cDNA spans this region [9]. 
From the Northern blot of human fibroblast total 
RNA, two glycosylasparaginase m ssages of 2.3 kb and 
1.5 kb were found in equal amount [IO]. Based on the 
distance separation of these polyadenylation signals in 
the 3’ exon, these two messages likely originate from 
differential use of the two signals, rather than from dif- 
ferential splicing of introns. /3-Hexosaminidase (Y chain 
has also been reported to have two transcripts using dif- 
ferent polyadenylation signals [ 151 I 
The gene structure of glycosylasparaginase will be 
helpful for characterization of mutations which cause 
AGU and should allow development of recombinant 
DNA probes to detect he disease and its genetic car- 
riers. So far only the major Finnish AGU mutation has 
been determined [9,10,28], and this is in exon 4 where 
G488 has been mutated to C. This point mutation results 
in the amino acid change CYS’~~ to Ser and creates a new 
EcoRI restriction site. PCR primers for the detection of 
this major point mutation have already been designed 
on the basis of the intron-exon structure of the gene 
[lo], and other non-Finnish mutations are now being 
studied in our laboratory [29]. Kaartinen et al. [7] 
recently described labelling the N-terminal threonine of 
the p (small) subunit of the human enzyme with an 
active-site inhibitor, DONV. This residue is in exon 5, 
and eventually natural or experimentally designed 
mutations coding this region of the human 
glycosylasparaginase gene may be discovered which can 
lead to a better understanding of the mechanism of this 
important lysosomal hydrolase. 
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